Cargando…
Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging global epidemic. The intention of this study was to explore the risk model and validation of CRKP infection in patients with cerebrovascular disease in the intensive care unit (ICU). The data of patients with cerebrovascular disease an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473460/ https://www.ncbi.nlm.nih.gov/pubmed/37663230 http://dx.doi.org/10.1515/med-2023-0774 |
_version_ | 1785100277803646976 |
---|---|
author | Liao, Qiuxia Feng, Zhi Chen, Xiaoli |
author_facet | Liao, Qiuxia Feng, Zhi Chen, Xiaoli |
author_sort | Liao, Qiuxia |
collection | PubMed |
description | Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging global epidemic. The intention of this study was to explore the risk model and validation of CRKP infection in patients with cerebrovascular disease in the intensive care unit (ICU). The data of patients with cerebrovascular disease and Klebsiella pneumoniae infection were retrospectively collected. The patients were divided into the CRKP group and the carbapenem-susceptible Klebsiella pneumoniae (CSKP) group. There were significant differences (P < 0.05) between the CRKP group and the CSKP group for many variables. Multivariate binary logistic regression analysis showed that the number of types of antibiotics used, history of glucocorticoid use, and duration of mechanical ventilation before the occurrence of infectious bacteria are the independent risk factors for CRKP infection in patients with cerebrovascular disease in the ICU, and a nomogram risk model was constructed accordingly. The area under the ROC curve of the risk model was 0.868 (95% CI: 0.803–0.934). |
format | Online Article Text |
id | pubmed-10473460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-104734602023-09-02 Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU Liao, Qiuxia Feng, Zhi Chen, Xiaoli Open Med (Wars) Research Article Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging global epidemic. The intention of this study was to explore the risk model and validation of CRKP infection in patients with cerebrovascular disease in the intensive care unit (ICU). The data of patients with cerebrovascular disease and Klebsiella pneumoniae infection were retrospectively collected. The patients were divided into the CRKP group and the carbapenem-susceptible Klebsiella pneumoniae (CSKP) group. There were significant differences (P < 0.05) between the CRKP group and the CSKP group for many variables. Multivariate binary logistic regression analysis showed that the number of types of antibiotics used, history of glucocorticoid use, and duration of mechanical ventilation before the occurrence of infectious bacteria are the independent risk factors for CRKP infection in patients with cerebrovascular disease in the ICU, and a nomogram risk model was constructed accordingly. The area under the ROC curve of the risk model was 0.868 (95% CI: 0.803–0.934). De Gruyter 2023-08-24 /pmc/articles/PMC10473460/ /pubmed/37663230 http://dx.doi.org/10.1515/med-2023-0774 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. |
spellingShingle | Research Article Liao, Qiuxia Feng, Zhi Chen, Xiaoli Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU |
title | Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU |
title_full | Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU |
title_fullStr | Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU |
title_full_unstemmed | Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU |
title_short | Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU |
title_sort | risk model and validation of carbapenem-resistant klebsiella pneumoniae infection in patients with cerebrovascular disease in the icu |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473460/ https://www.ncbi.nlm.nih.gov/pubmed/37663230 http://dx.doi.org/10.1515/med-2023-0774 |
work_keys_str_mv | AT liaoqiuxia riskmodelandvalidationofcarbapenemresistantklebsiellapneumoniaeinfectioninpatientswithcerebrovasculardiseaseintheicu AT fengzhi riskmodelandvalidationofcarbapenemresistantklebsiellapneumoniaeinfectioninpatientswithcerebrovasculardiseaseintheicu AT chenxiaoli riskmodelandvalidationofcarbapenemresistantklebsiellapneumoniaeinfectioninpatientswithcerebrovasculardiseaseintheicu |